Abstract. Merozoite surface antigen 1 (MSA1) is a promising candidate for vaccine development against malaria parasites. Here, we report the complete nucleotide sequence of the gene encoding the precursor to this major surface antigen of Plasmodium berghei strain ANKA using cDNA library screening and polymerase chain reaction techniques. A single open reading frame of 5,376 basepairs encoding a protein with a calculated molecular mass of 197 kD was defined. The protein contains a putative signal peptide of 19 amino acids, a membrane anchor sequence of 18 residues, and shows two epidermal growth factor-like domains rich in Cys residues at the C-terminus. There are four repeat sequences of oligopeptides in the molecule: tetrapeptide (Ser-Thr-Thr-Thr), tripeptide (Pro-Thr-Pro and Pro-Ala-Ala), and dipeptide (Ser-Gly). Furthermore, three nine-residue stretches of a motif (Ala-Ser-Asn-Pro-Gly-Ala-Ser-Ala-Ser) are located near each other. All of these repeat sequences are unexceptionally located in the variable regions when compared with other MSA1 molecules. The molecule displays 79% overall identity to the analogous antigen of P. yoelii yoelii strain YM, 70% to that of P. chabaudi chabaudi strain AS, and 38% to that of P. falciparum strain Wellcome.
Malaria is one of the most important infectious human diseases in the world today. It is estimated by the World Health Organization that there are up to 300 million people infected with malaria yearly, which accounts for up to two million deaths each year, mostly in infants or very young children. 1 Despite intense research either to eradicate malaria or lessen its fatality and morbidity, an effective control strategy still remains to be achieved. Malaria is transmitted exclusively by the Anopheles mosquito and may also undergo transplacental and blood transfusion-associated transmission. Among the four known human malaria parasites, Plasmodium falciparum is the most virulent and life-threatening. Infection with this parasite can result in cerebral malaria, a major cause of death. Commonly used disease control tools such as antiparasitic drugs and insecticides have become less effective and malaria vaccine development remains a high priority.
In the search for vaccines against malaria, one candidate antigen is an asexual stage protein present on the surface of the invasive merozoite, the merozoite surface antigen (MSA1). This is thought to be involved in attachment/recognition and subsequent invasion into the erythrocyte. 2 People living in malaria-endemic areas have MSA1-specific antibodies in their blood. [3] [4] [5] It is of particular importance that one member of this protein family, Py230, has been shown to be able to induce a protective response in a mouse model against an otherwise lethal malarial challenge with P. yoelii. 6 A passive transfer of monoclonal antibodies reacting with MSA1 can also confer resistance in mice against a lethal challenge by P. yoelii. 7 We chose the murine parasite species P. berghei (ANKA strain) to study infection and immunologic reactions in a rodent model. This species is well characterized 8 and it resembles P. falciparum in that both are very virulent to the host and their infections cause similar (albeit not identical) pathologic complications including anemia, renal disease, thrombocytopenia, pulmonary edema, and cerebral malaria. The isolation of the MSA1 gene from P. berghei was undertaken.
MATERIALS AND METHODS

Preparation of parasites.
Plasmodium berghei (ANKA strain) was a kind gift from Dr. G. Grau (Geneva, Switzerland). A total of 1 ϫ 10 4 parasitized mouse erythrocytes were injected into each animal intraperitoneally. Parasitemia was determined by counting the percentage of infected red blood cells after Giemsa-staining. When the parasitemia increased above 70%, the mice were killed and their blood was collected in a heparinized tube. The blood was centrifuged at 650 ϫ g in a benchtop centrifuge, and the pellet was washed three times with 1ϫ phosphate-buffered saline (PBS; 1mM NaH 2 PO 4 , 0.85% NaCl, pH 7.4). The blood cell pellet was then resuspended in PBS for reinfection into naive animals, or for storage in liquid nitrogen.
Isolation of RNA and purification of mRNA. Isolation of total RNA was performed using a kit according to the manufacturer's instructions (RNA isolation kit; Stratagene, Inc., La Jolla, CA) following lysis of the parasitized erythrocytes. The RNA was resuspended in 500 l of diethylpyrocarbonate-treated water and its concentration was determined by reading its absorbance at 260 nm (A 260 ).
Presumed mRNA was isolated with a biotinylated probe using a purification kit (Promega, Inc., Madison, WI) and concentrated by precipitation with ethanol.
Synthesis of cDNA and library construction. A SuperScript DNA synthesis kit (Gibco-BRL, Gaithersburg, MD) was used for cDNA synthesis. Library preparation was accomplished with this using a ZAPII vector (EcoRIarmed; Stratagene, Inc.) according to the instructions of the manufacturer. To determine the efficiency of construction, 1 l of the reaction was mixed with 200 l of the XL1-Blue host cells (Stratagene, Inc.) at an A 600 ϭ 0.5 and preincubated at 37ЊC for 15 min, 2-3 ml of top agar (48ЊC) was added, followed by 15 l of 0.5 M isopropyl ␤-thiogalactoside (in water) and 50 l of 5-bromo-4-chloro-3-indolyl ␤-D-galactopyranoside (250 mg/ml in dimethylformamide), and the mixture was plated onto NZY plates (Gibco-BRL). After incubation at 37ЊC for 6-8 hr, the ratio of the white recombinant plaques to the background blue ones was determined.
Screening the cDNA library. The probe was synthesized according to the previously published partial sequence of the MSA1 gene of P. berghei: 9 5Ј-TTAAATAACTTAAATAA-ATCTGGTTTGGTAGGAGAAGGCGAATCGAAAAAAA-TATTAGCAAAA-3Ј, and 3Ј-end-labeled with fluorescein-UTP (Amersham, Inc., Arlington Heights, IL). A total of 10 6 plaques were primarily screened and the putatively positive clones were picked, titered, and secondarily screened. The positive phages coinfected Escherichia coli SOLR strain cells with the helper phages and formed circular phagemids by in vivo excision. The transformed bacterial colonies were screened with a polymerase chain reaction (PCR) procedure. The colony was resuspended in 20 l of water and boiled for 10 min. Ten microliters of water containing the picked colony was mixed with 10 l of PCR buffer, AmpliTaq DNA polymerase (Perkin-Elmer, Norwalk, CT) (2.5 units/ 100 l), and primers (1.0 M) each and cycled as follows: denaturation at 94ЊC for 1 min, annealing at 50ЊC for 1 min, and extension at 72ЊC for 2 min for a total of 30 cycles. The clones that produced a 250-basepair (bp) fragment by the PCR were isolated.
Identification and sequencing of the cDNA clones. The positive clones were isolated and plasmid DNA was purified by a miniprep procedure. 10 The size of the insert was determined by digestion with Eco RI, followed by gel electrophoresis. The inserts were sequenced by the dideoxynucleotide termination method. 11 Purification of genomic DNA. Genomic DNA was purified according to the procedure of the manufacturer (Wizard Genomic Purification Kit; Promega Corp.). The DNA was dissolved by adding 100 l of DNA hydration solution and the concentration was determined by rapid agarose gel electrophoresis (Promega Corp.).
Hot-start PCR. A hot-start PCR was performed according to the procedure of Chou and others with some modifications (the starting temperature was 60ЊC and cycles were 75 sec). 12 The 4.3-kb PCR band was excised from the 0.8% agarose gel and purified using a GeneClean II Kit (Bio101, Inc., La Jolla, CA) with silica matrix as absorbent and lowsalt solution as recovery reagent. 13 Cloning of the PCR product. The PCR product was cloned into the pNoTA/T7 vector using a Prime PCR Cloner cloning system (5 Prime → 3 Prime, Inc., Boulder, CO). The concentration of purified PCR product was determined by measuring the A 260 . Competent cells (E. coli JM109) were screened and white clones were selected and analyzed by mini-prep DNA isolation followed by digestion with restriction enzymes.
Autosequencing. Sequencing was done using an ABI 377 DNA autosequencer (Applied Biosystems, Foster City, CA) based on fluorescence methodology using the PRISM Ready Reaction DyeDeoxy Terminator Cycle Sequencing Kit (Perkin-Elmer).
RESULTS
Characteristics of the 3-untranslated region (UTR) of the MSA1 cDNA clones. The cDNA clones were selected based on hybridization with the described probe. Six clones were examined in detail.
The insert of one of the cDNA clones was composed of a coding sequence of 1,143 bp and a 3Ј-UTR) of 467 bp (Figure 1 ). It is apparent that this 3Ј-UTR sequence does not contain a long stretch of a poly(A) tail, although two eukaryotic poly(A) signals (AAUAAA) can be found about 140 and 400 bp downstream of the stop codon. In the 3Ј-UTR of another cDNA clone, the termination site of the 3Ј-UTR is just four bases downstream of the 140 bp poly(A) signal. It is possible that the mRNA of MSA1 can be isolated as polyAϩ by oligo-dT column chromatography because of stretches of adenines inside the genes although there is no direct evidence that this is the case. Since they are located either very near (Ͻ 5 bp) or far (Ͼ 60 bp), respectively, from the termini, rather than the usual 10-30 bp upstream, and the spacing of the signal is very important for the proper functioning of the 3Ј-end processing complex, 14 it is unlikely these sequences function as polyadenylation signals in parasites. This is consistent with reports that RNA from the asexual stage of P. falciparum 15, 16 and P. yoelii, 17 as well as from sporozoites of P. berghei, 18 comprise poly(A)-minus mRNAs that can be translated in vitro. Furthermore, the termination site or modification of the 3Ј-end of the mRNA transcript appears heterogenous, 19 but not random. Interestingly, a microsatellite-like repeat of 20 AT dinucleotides has been found in the middle of the 3Ј-UTR, which is beyond the terminus of the shorter 3Ј-UTR and may be responsible for the aggravation of the attenuation and termination of transcription. It may serve as a useful marker to pinpoint the location of the MSA1 on the parasite chromosome.
Sequence analysis of the coding sequence of MSA1 of P. berghei. Since the MSA1 gene is very conserved between species both at the 5Ј and 3Ј ends of the coding sequences, even the genomic sequences upstream of the start codon, as shown in Figure 2 , are highly homologous to each other. It is therefore feasible to amplify the 5Ј genomic sequence by a hot-start PCR using one upstream homology primer (U0) and another downstream one (2892) from the C-terminal cDNA sequence. The U0 primer sequence is 5Ј-CTTTAA-TATTTATTTTTACACAAATTAG-3Ј while the 2892 sequence is 5Ј-TAATCCAGTTGTCATGTCTTCTTTAATTG TTGA-3Ј. The PCR product was cloned in the pNoTA/T7 vector and the recombinant plasmid DNA was sequenced. Since no MSA1 gene found thus far contains any intron in the coding sequence, 20,21 a combination of the sequence of the PCR product with that of C-terminal cDNA clones was done to form a putative sequence of the MSA1 gene of P. berghei. It is recognized that the specific genomic sequence has not been determined directly. In addition, no deviation was observed when different PCR product sequences were compared.
The entire MSA1 region studied spans 5,967 bp, which includes a 467 bp 3Ј-UTR (Figure 1 ), a 5,376 bp coding sequence (Figure 3) , and a 124 bp sequence 5Ј-upstream of the presumed start codon (Figure 2 ). It should be emphasized that neither the 3Ј nor the 5Ј termini of the gene have been explicitly identified. This sequence codes for a protein of deduced 1,791 amino acids with a calculated molecular mass of 197 kD. The AT content is very high with an average of 69% in the coding region and higher beyond, a common phenomenon for malarial genes. 22 The 5Ј sequence upstream from the start codon contains a TATA box (bp 35-38), followed by two possible capping signals. 23 It has been observed that two stop codons (TAG and TGA) are immediately upstream from the start codon and a stretch of three adenines precedes the start codon, which suggests that this ATG is the correct translation initiation start site. 24 In addition, the 5Ј-end sequence of 19 amino acids starting from the ATG codon is homologous to that of other MSA1 genes and has all the characteristics of a signal peptide. 25 Besides the putative signal peptide, an 18-residue, hydrophobic, glycosyl phosphatidylinositol anchor sequence was found in the molecule at the 3Ј-end (residues 1774-1791). Taken together, these data strongly suggest that this molecule is a membrane-anchored cell surface protein. There are 20 Cys residues in the molecule, half of which are located in the last 100 amino acids of the protein, which indicates an important role of the carboxyl terminus. Furthermore, between residues 813 and 1374, there are four regions with repeat oligopeptides: tetrapeptide (Ser-Thr-Thr-Thr), tripeptide (Pro-Thr-Pro and Pro-Ala-Ala), and dipeptide (Ser-Gly). Ten potential N-glycosylation sites with the motif Asn-XSer/Thr (where X is any amino acid except proline) scatter throughout the protein.
Comparison of the P. berghei, P. yoelii, P. chabaudi, P. falciparum, and P. vivax sequences. Comparison of the deduced amino sequence from P. berghei with that from other species shows an overall identity of 37.5% with P. falciparum strain Wellcome, 44.5% with P. vivax, 70% with P. chabaudi strain AS, and 77% with P. yoelii strain YM. All of these proteins are processed to a set of daughter polypeptides and are present on the merozoite surface as a noncovalent assembly. Several of the processing sites 26 (LB-Leu-↓-S-Ile/Val, where LB represents a large hydrophobic residue, and S represents a small amino acid such as glycine), are conserved among all the five MSA1 genes noted above or within the murine species. These data indicate that the processing of the MSA1 protein is critical to function and may not be an artificial phenomenon. 27 Of the 10 Cys residues at the carboxyl terminal of P. berghei MSA 1, all of them are conserved in MSA1 proteins of other species; the P. falciparum protein has an extra two cysteines. The last six Cys residues have a CXnCXnCXnCXC XnGXC (where X is any residue, C is cysteine, and G is glycine) consensus motif without any variation in five MSA1 molecules. DISCUSSION We have reported the cloning and sequencing of the complete coding sequence for the merozoite surface antigen from P. berghei strain ANKA. Prior reports have provided partial sequences of this protein from a related strain (K173) as well as from the ANKA strain. 28, 29 In the former case, the sequence data are in complete agreement; there are a few discrepancies in the latter sequence beginning near nucleotide 700. The reasons for this are not known. The MSA1 of P. berghei exhibits sequence similarity to other MSA1 genes. It contains putative signal and anchor sequences, potential glycosylation sites, a cluster of Cys residues that possibly form the epidermal growth factor-like domains at the carboxyl terminus of the MSA1 molecule, and specific repeat sequences.
The P. falciparum MSA1 sequence has been divided into 17 blocks according to three levels of conservation of amino acids among different Pf195 alleles: conserved, semiconserved, and variable regions. 30, 31 Comparison of MSA1 of P. berghei with that of P. yoelii 32 and P. vivax indicates that while the MSA1 molecules of the murine species remain highly homologous (Ͼ 80% similarity), those of P. vivax and P. falciparum show less resemblance to the MSA1of P. berghei; this is summarized in Figure 4 . It is of interest that all five repeat motifs of MSA1 of P. berghei are located in a region that contains abundant proline and glycine residues, and is likely to form random coils or loops connecting functional domains. The repeat region has been shown to be highly immunogenic. 
